MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org on October 23, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on October 23, 2015. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Erythropoietin for anemia of renal failure in sickle cell disease.
A pharmacodynamic model of erythropoietin therapy for uremic anemia.
Erythropoietin concentration in amphotericin B-induced anemia.
Reduced erythropoietin secretion in senile anemia.
Amphotericin B blunts erythropoietin response to anemia.
Recombinant erythropoietin therapy in renal and nonrenal anemia.
Treatment of renal anemia with recombinant human erythropoietin.
The treatment of anemia with low-dose recombinant human erythropoietin.
Erythropoietin and cancer: the unintended consequences of anemia correction.
[Role of erythropoietin deficiency in the pathogenesis of renal anemia].
Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
Effect of erythropoietin on anemia of peritoneally dialyzed anephric rats.
Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology.
Evaluation of erythropoietin levels in the anemia of thermal injury.
Erythropoietin treatment of anemia associated with multiple myeloma.
Improvement in anemia by recombinant human erythropoietin in patients with myelodysplastic syndrome and aplastic anemia.
Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia.
Cost-effectiveness of continuous erythropoietin receptor activator in anemia.
Erythropoietin in anemia of renal failure in sickle cell disease.
Evidence for renal vasodilation in pre-dialysis patients during correction of anemia by erythropoietin.
Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration.
Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
Recombinant human erythropoietin for anemia of end-stage renal failure in beta thalassemia trait.
Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
Erythropoietin for zidovudine-induced anemia.
The New England Journal of Medicine Downloaded from nejm.org on October 23, 2015. For personal use only. No other uses without permission. Copyright ©...
419KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Erythropoietin for anemia of renal failure in sickle cell disease.
A pharmacodynamic model of erythropoietin therapy for uremic anemia.
Erythropoietin concentration in amphotericin B-induced anemia.
Reduced erythropoietin secretion in senile anemia.
Amphotericin B blunts erythropoietin response to anemia.
Recombinant erythropoietin therapy in renal and nonrenal anemia.
Treatment of renal anemia with recombinant human erythropoietin.
The treatment of anemia with low-dose recombinant human erythropoietin.
Erythropoietin and cancer: the unintended consequences of anemia correction.
[Role of erythropoietin deficiency in the pathogenesis of renal anemia].
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms